PMA supplement

BP050009 S004: Clearview COMPLETE HIV 1/2

FDA PMA supplement · Special Supplement · Chembio Diagnostic Systems, In

Key facts

Original PMA BP050009
Supplement number S004
Supplement type Special Supplement
Trade name Clearview COMPLETE HIV 1/2
Generic name Point of care hiv serology diagnostic and/or supplemental test
Applicant Chembio Diagnostic Systems, In
Product code QSU
Received date Jul 13, 2007
Decision date Sep 4, 2007

At a glance

  • No Expedited review granted
  • No Approval order on file
  • No Summary of safety and effectiveness on file

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMA supplements

A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.

Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date:

Browse all PMA supplements